Agarwal, Sarita and Tamhankar, P.M. and Kumar, R. and Dalal, Ashwin (2010) Clinical and haematological features in a compound heterozygote (HBB:c.92 + 5G > C/HBB:c.93-2A > C) case of thalassaemia major. International Journal of Laboratory Hematology, 32 (3). pp. 369-372. ISSN 1751-5521

Text Int J Lab Hematol 32 p369.pdf Restricted to Repository staff only Download (114Kb) | Request a copy

Abstract

An Indian Muslim boy was diagnosed with thalassaemia major at 3 months of age. His blood investigations revealed haemoglobin: 5.3 gm%, MCV: 68 fl, MCH 26.6 pg, MCHC: 39%, haemoglobin variant analysis: HbA(2): 2.8%, HbF: 20.3% and HbA: 75.2% (post-transfusion). His fathers' haemoglobin was 10.2 gm%, MCV: 68 fl, MCH: 23.9 pg, MCHC: 35% HbA(2): 4.7%, HbF: 0.7% and HbA: 85.2% and his mothers' haemoglobin was 10.9 gm%, MCV: 67.4 fl, MCH 22.6 pg, MCHC: 33.5%, HbA(2): 5.3%, HbF: 0% and HbA: 85.4%. The boy was found to be compound heterozygote for beta globin gene mutations (HBB:c.92 + 5G > C/HBB:c.93-2A > C). The mutation HBB:c.93-2A > C was inherited from his father. This report confirms the presence of HBB:c.93-2A > C in the Indian subcontinent and has important implications for screening and prenatal diagnosis of beta thalassaemia. This report also supports inclusion of this mutation in the beta globin gene mutation database.

Item Type:	Article
Depositing User:	Users 2 not found.
Date Deposited:	31 Aug 2015 08:43
Last Modified:	12 Oct 2015 08:41
URI:	http://cdfd.sciencecentral.in/id/eprint/417

Actions (login required)

View Item